Therapeutics Acquisition Corp. Uncategorized Contracts & Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 2 dated April 17, 2023 to Sublicense Agreement dated November 14, 2019 between POINT Theranostics Inc. and Scintomics GmbH
Therapeutics Acquisition Corp.
Biotechnology
2023
Amendment No. 1 dated April 17, 2023 to Sublicense Agreement dated November 14, 2019 between POINT Theranostics Inc. and Scintomics GmbH
Therapeutics Acquisition Corp.
Biotechnology
2023
Fourth Amendment dated May 6, 2022 to Exclusive Sublicense Agreement dated April 2, 2020
Therapeutics Acquisition Corp.
Biotechnology
2022
Sublicense Agreement dated November 14, 2019 between POINT Theranostics Inc. and Scintomics GmbH
Therapeutics Acquisition Corp.
Biotechnology
2022
Description of Securities
Therapeutics Acquisition Corp.
Biotechnology
2022
Revised Form of
Therapeutics Acquisition Corp.
Biotechnology
2021
Revised Form of Non
Therapeutics Acquisition Corp.
Biotechnology
2021
Third Amendment to Exclusive Sublicense Agreement, dated September 24, 2021, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
Second Amendment to Exclusive Sublicense Agreement, dated January 5, 2021 to be effective as of December 31, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
First Amendment to Exclusive Sublicense Agreement, dated April 14, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
Exclusive Sublicense Agreement, dated April 2, 2020, between Bach Biosciences, LLC and POINT Biopharma Inc
Therapeutics Acquisition Corp.
Biotechnology
2021
Description of the Companys securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
Therapeutics Acquisition Corp.
Biotechnology
DE
2021
Letter Agreement, dated July 7, 2020, by and among the Company, its officers, its directors and Therapeutics Acquisition Holdings, LLC
Therapeutics Acquisition Corp.
Biotechnology
2020
Form of Letter Agreement among the Registrant and each director and executive officer of the Registrant
Therapeutics Acquisition Corp.
Biotechnology
2020
Form of Letter Agreement among the Registrant and each director and executive officer of the Registrant
Therapeutics Acquisition Corp.
Biotechnology
2020
Form of Indemnity Agreement
Therapeutics Acquisition Corp.
Biotechnology
DE
2020
Specimen Unit Certificate
Therapeutics Acquisition Corp.
Biotechnology
2020